Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5208955
Max Phase: Preclinical
Molecular Formula: C45H49FN8O8
Molecular Weight: 848.93
Associated Items:
ID: ALA5208955
Max Phase: Preclinical
Molecular Formula: C45H49FN8O8
Molecular Weight: 848.93
Associated Items:
Canonical SMILES: O=C1CCC(N2C(=O)c3cccc(NC(=O)CNCCCCCCCCCC(=O)N4CCN(C(=O)c5cc(Cc6n[nH]c(=O)c7ccccc67)ccc5F)CC4)c3C2=O)C(=O)N1
Standard InChI: InChI=1S/C45H49FN8O8/c46-33-17-16-28(26-35-29-11-7-8-12-30(29)41(58)51-50-35)25-32(33)43(60)53-23-21-52(22-24-53)39(57)15-6-4-2-1-3-5-9-20-47-27-38(56)48-34-14-10-13-31-40(34)45(62)54(44(31)61)36-18-19-37(55)49-42(36)59/h7-8,10-14,16-17,25,36,47H,1-6,9,15,18-24,26-27H2,(H,48,56)(H,51,58)(H,49,55,59)
Standard InChI Key: OANIAMLFYSYIJN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 848.93 | Molecular Weight (Monoisotopic): 848.3657 | AlogP: 3.69 | #Rotatable Bonds: 17 |
Polar Surface Area: 211.05 | Molecular Species: BASE | HBA: 10 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 16 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 9.95 | CX Basic pKa: 8.63 | CX LogP: 3.29 | CX LogD: 2.22 |
Aromatic Rings: 4 | Heavy Atoms: 62 | QED Weighted: 0.09 | Np Likeness Score: -1.08 |
1. Pu C, Wang S, Luo D, Liu Y, Ma X, Zhang H, Yu S, Lan S, Huang Q, Deng R, He X, Li R.. (2022) Synthesis and biological evaluation of a tumor-selective degrader of PARP1., 69 [PMID:35780655] [10.1016/j.bmc.2022.116908] |
Source(1):